Nahmias is a professor at the Hebrew University of Jerusalem and an affiliated member of the NIH-funded BioMEMS Resource Center at Massachusetts General Hospital.
[1] In 2014, he won the Rappaport Prize for Biomedical Sciences for his “groundbreaking work on liver tissue engineering” and the “development of nanotechnology therapies for the treatment of diabetes”.
[2][3] Nahmias edited a book titled Microdevices in Biology and Medicine, and is currently serving as a technology consultant for L’Oreal,[4] and a member of the European Research Council panel for applied life sciences and biotechnology.
[7] He completed his PhD at the University of Minnesota with David Odde,[8] and his postdoctoral training at Harvard Medical School with Martin Yarmush.
[9] Nahmias moved to the Hebrew University of Jerusalem in 2009, where he won two major European Research Council (ERC) Starting and Consolidator Grants,[10][11] and founded the Alexander Grass Center for Bioengineering.